NCT00304642View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

November 30, 2005

Conditions
HIV Infections
Interventions
DRUG

dapivirine (TMC120) vaginal gel

Trial Locations (1)

Unknown

Farmovs-Parexel, Bloemfontein

All Listed Sponsors
lead

International Partnership for Microbicides, Inc.

INDUSTRY

NCT00304642 - A Study to Assess the Pharmacokinetics of Dapivirine (TMC120) Vaginal Microbicide Gel | Biotech Hunter | Biotech Hunter